Plerixafor (AFT) TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: plerixafor
Pack: Plerixafor (AFT) 24 mg/1.2 mL injection, 1.2 mL vial
Brand name
(ARTG)
: Plerixafor-AFT plerixafor 24 mg/1.2 mL solution for injection vialDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Plerixafor-AFT is indicated in combination with granulocyte-colony stimulating factor (G-CSF) to mobilise haematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with lymphoma and multiple myeloma (MM).
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, solution
- Subcutaneous
- A clear, colourless, sterile, preservative-free, practically free from visible particles, isotonic solution supplied in a 2 mL clear glass vial
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 48 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 1 Vial pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient plerixafor
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
